Cargando…
A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720146/ https://www.ncbi.nlm.nih.gov/pubmed/35005666 http://dx.doi.org/10.1016/j.lanwpc.2021.100353 |
_version_ | 1784625080206098432 |
---|---|
author | Putong, Nimfa Agrupis, Kristal An Villanueva, Annavi Marie Suzuki, Shuichi Sayo, Ana Ria Dimaano, Efren de Guzman, Ferdinand Teaño, Ruel Salazar, Mary Jane Evangelista, Jan Wendzl Dimapilis, Alexis Villarama, Jose Benito Ariyoshi, Koya Takahashi, Kensuke Smith, Chris |
author_facet | Putong, Nimfa Agrupis, Kristal An Villanueva, Annavi Marie Suzuki, Shuichi Sayo, Ana Ria Dimaano, Efren de Guzman, Ferdinand Teaño, Ruel Salazar, Mary Jane Evangelista, Jan Wendzl Dimapilis, Alexis Villarama, Jose Benito Ariyoshi, Koya Takahashi, Kensuke Smith, Chris |
author_sort | Putong, Nimfa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8720146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87201462022-01-03 A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines Putong, Nimfa Agrupis, Kristal An Villanueva, Annavi Marie Suzuki, Shuichi Sayo, Ana Ria Dimaano, Efren de Guzman, Ferdinand Teaño, Ruel Salazar, Mary Jane Evangelista, Jan Wendzl Dimapilis, Alexis Villarama, Jose Benito Ariyoshi, Koya Takahashi, Kensuke Smith, Chris Lancet Reg Health West Pac Correspondence Elsevier 2022-01-01 /pmc/articles/PMC8720146/ /pubmed/35005666 http://dx.doi.org/10.1016/j.lanwpc.2021.100353 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Correspondence Putong, Nimfa Agrupis, Kristal An Villanueva, Annavi Marie Suzuki, Shuichi Sayo, Ana Ria Dimaano, Efren de Guzman, Ferdinand Teaño, Ruel Salazar, Mary Jane Evangelista, Jan Wendzl Dimapilis, Alexis Villarama, Jose Benito Ariyoshi, Koya Takahashi, Kensuke Smith, Chris A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines |
title | A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines |
title_full | A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines |
title_fullStr | A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines |
title_full_unstemmed | A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines |
title_short | A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines |
title_sort | call to protect non-clinical frontliners in the fight against covid-19: evidence from a seroprevalence study in the philippines |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720146/ https://www.ncbi.nlm.nih.gov/pubmed/35005666 http://dx.doi.org/10.1016/j.lanwpc.2021.100353 |
work_keys_str_mv | AT putongnimfa acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT agrupiskristalan acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT villanuevaannavimarie acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT suzukishuichi acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT sayoanaria acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT dimaanoefren acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT deguzmanferdinand acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT teanoruel acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT salazarmaryjane acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT evangelistajanwendzl acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT dimapilisalexis acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT villaramajosebenito acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT ariyoshikoya acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT takahashikensuke acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT smithchris acalltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT putongnimfa calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT agrupiskristalan calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT villanuevaannavimarie calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT suzukishuichi calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT sayoanaria calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT dimaanoefren calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT deguzmanferdinand calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT teanoruel calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT salazarmaryjane calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT evangelistajanwendzl calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT dimapilisalexis calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT villaramajosebenito calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT ariyoshikoya calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT takahashikensuke calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines AT smithchris calltoprotectnonclinicalfrontlinersinthefightagainstcovid19evidencefromaseroprevalencestudyinthephilippines |